![Julie Dechanet-Merville](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julie Dechanet-Merville
Directeur/Bestuurslid bij Lymphact - Lymphocyte Activation Technologies SA
Actieve functies van Julie Dechanet-Merville
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Lymphact - Lymphocyte Activation Technologies SA
![]() Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Directeur/Bestuurslid | - | - |
Loopbaan van Julie Dechanet-Merville
Statistieken
Internationaal
Portugal | 2 |
Operationeel
Director/Board Member | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Lymphact - Lymphocyte Activation Technologies SA
![]() Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Health Technology |